BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 194426)

  • 1. [E1The mechanism of action of Lupidon].
    Remy W
    Z Hautkr; 1977 Apr; 52(8):470-4. PubMed ID: 194426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antibody titers--curse in patients with recurring Herpes simplex virus infections under vaccination with heat-inactivated Herpes viruses].
    Remy W; Antoniadis G; Bockendahl H; Remy B
    Z Hautkr; 1976 Feb; 51(3):103-7. PubMed ID: 183397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of recurrent herpes simplex].
    Eichmann A
    Z Hautkr; 1977 Apr; 52(8):475-82. PubMed ID: 194427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled clinical study of the herpes antigens LUPIDON H and LUPIDON G].
    Weitgasser H
    Z Hautkr; 1977 Jun; 52(11):625-8. PubMed ID: 196421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of treatment with the Herpes simplex antigen Lupidon H, resp. Lupidon G].
    Schmersahl P; Rüdiger G
    Z Hautkr; 1975 Feb; 50(3):105-12. PubMed ID: 179231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antigen therapy of recurring herpes simplex with herpes simplex vaccine LUPIDON H and G].
    Schneider J; Rohde B
    Z Haut Geschlechtskr; 1972 Dec; 47(24):973-80. PubMed ID: 4346378
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases.
    Leventon-Kriss S; Rannon L; Joffe R
    Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Oncogeny of herpes simplex viruses and lupidon].
    Petersen EE
    Z Hautkr; 1977 Apr; 52(7):417-26. PubMed ID: 193311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy experiences with herpes simplex antigen "Lupidon G".
    Djuanda S
    J Dermatol; 1976 Oct; 3(5):241-6. PubMed ID: 191480
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the neutralizing antibody to herpes simplex virus. III. Detection of type-specific antibody by slow-reacting complement-requiring neutralizing antibody assay.
    Ohashi M; Ozaki Y
    Microbiol Immunol; 1982; 26(7):569-74. PubMed ID: 7132789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex neutralizing antibody--quantitation of the complement-dependent fraction in different phases of adult human infection.
    Heineman HS
    J Immunol; 1967 Jul; 99(1):214-22. PubMed ID: 4291444
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical aspects and importance of human herpex simplex infections. Results of herpes antigen therapy].
    Wassilew SW; Nasemann T
    MMW Munch Med Wochenschr; 1980 Jan; 122(1):25-7. PubMed ID: 6245350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactions of immune sera against the nucleocapsid, envelope and whole herpes simplex virus type 1.
    Lesso J; Hána L; Matis J
    Acta Virol; 1976 Feb; 20(1):48-52. PubMed ID: 7940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immune response in genital herpes simplex virus infection.
    Corey L; Reeves WC; Holmes KK
    N Engl J Med; 1978 Nov; 299(18):986-91. PubMed ID: 211414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus antibodies in 18 patients submitted to immunosuppressive agents after renal transplantation].
    Ruffault A; Fauconnier B; Cartier F; Launois B
    Pathol Biol (Paris); 1975 May; 23(5):371-4. PubMed ID: 172840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Type-specificity of slow-reacting complement-requiring neutralizing antibody (s-CRN antibody) to herpes simplex virus types 1 and 2 in rabbits].
    Sekine N
    Uirusu; 1983 Jun; 33(1):47-55. PubMed ID: 6316659
    [No Abstract]   [Full Text] [Related]  

  • 17. Protection of newborn mice from a lethal herpes simplex virus infection by human interferon, antibody, and leukocytes.
    Kohl S; Loo LS; Greenberg SB
    J Immunol; 1982 Mar; 128(3):1107-11. PubMed ID: 6173420
    [No Abstract]   [Full Text] [Related]  

  • 18. [Investigations concerning the evidence of herpes simplex virus type 2 (HSV-2) antibodies in patients with carcinoma of the cervix (author's transl)].
    Dostal V; Fanta D; Reiss-Gutfreund RJ; Janisch H; Berger R
    Wien Klin Wochenschr; 1977 Mar; 89(6):201-3. PubMed ID: 191994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L; Vonka V; Slichtová V
    Acta Virol; 1980 Dec; 24(6):391-8. PubMed ID: 6111199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Specific and unspecific immune stimulation in recurrent herpes simplex].
    Raab W
    Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.